Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: It is a violation to ask Agora to review a violation!

So you assume that the majority of outstanding shares were purchased at $1 or $1.50 ............... highly, highly suspect at best.

But to take it a step further, we have been led to believe that the MMP is of such value that perhaps our take could be over a half billion dollars. Are the chances of shareholder value enhancement greater by returning such funds to the shareholders, or by allowing to BoD to squander the funds by authorizing horrific 'investments' as history confirms. Most 'see' the difference in value, some prefer the status quo.

Share
New Message
Please login to post a reply